Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Androgens may block hair growth signals, targeting this could treat hair loss.

Mice without the Sp6 gene have problems developing several body parts, including hair, teeth, limbs, and lungs.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Two gene areas linked to male pattern baldness found, more research needed.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

A gene mutation in mice causes permanent hair loss and skin issues.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

The document concludes that more research is needed to create specific drugs for treating male pattern baldness.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Cosmetic foam product reduces hair loss and increases hair density in men.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

New genes linked to male pattern baldness were found on chromosome 20p11.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

Certain gene changes and hormone levels are linked to female hair loss.